
TMS Co., Ltd. (Securities Code: 4891) is a biotech venture originating from the Tokyo Un

TMS Co., Ltd. (4891) has released its financial results, reporting an operating loss of 392 million yen, ordinary loss of 392 million yen, and a net loss of 393 million yen, with earnings per share (E